During the past decade, Intercoastal Medical Group conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 12 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Intercoastal Medical Group" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Eisai Inc." with 2 trials sponsored, "Enterin Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Intercoastal Medical Group" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Intercoastal Medical Group" are "Alzheimer Disease" (7 trials), "Cardiovascular Disease" (3 trials), "Constipation" (2 trials), "Ischemic Stroke" (2 trials) and "Parkinson Disease" (2 trials). Many other conditions were trialed in "Intercoastal Medical Group" in a lesser frequency.

Most popular intervention types in "Intercoastal Medical Group" are "Drug" (22 trials), "Device" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Active Investigational Treatment ENT-01" (2 trials), "Donanemab" (2 trials), "Gantenerumab" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Intercoastal Medical Group" are 23 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Intercoastal Medical Group". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Intercoastal Medical Group, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Intercoastal Medical Group, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Intercoastal Medical Group has several departments that took part in Clinical trials: "Intercoastal Neurology" - 2 trials